These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2326770)

  • 1. Comparison of methods for detecting soluble fibrin in plasma. An in vitro study.
    Halvorsen S; Skjønsberg OH; Ruyter R; Godal HC
    Thromb Res; 1990 Feb; 57(4):489-97. PubMed ID: 2326770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of soluble fibrin monomer complexes. Comparison of a haemagglutination assay with the ethanol gelation test.
    Oehler G; Klaus H; Stötzer KE; Spanuth E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):278-83. PubMed ID: 2465216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunction.
    Sørensen JV; Jensen HP; Rahr HB; Borris LC; Lassen MR; Fedders O; Haase JP; Knudsen F
    Haemostasis; 1993; 23(2):91-7. PubMed ID: 8365691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative sensitivity of different methods to detect and quantify circulating fibrinogen/fibrin split products.
    Drewinko B; Surgeon J; Cobb P; Callahan L; Schmidt D; Bollinger P; Trujillo JM
    Am J Clin Pathol; 1985 Jul; 84(1):58-66. PubMed ID: 3893094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc inhibits FPA release and increases fibrin turbidity.
    Marx G; Hopmeier P
    Am J Hematol; 1986 Aug; 22(4):347-53. PubMed ID: 3728455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
    Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
    Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of soluble fibrin: a comparison of four different methods.
    Wieding JU; Hosius C
    Thromb Res; 1992 Mar; 65(6):745-56. PubMed ID: 1636166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
    Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin treated plasma employed as a standard for determination of soluble fibrin.
    Halvorsen S; Skjønsberg OH; Godal HC
    Thromb Res; 1993 Nov; 72(4):305-13. PubMed ID: 8303670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immunological and functional assays for measurement of soluble fibrin.
    Dempfle CE; Pfitzner SA; Dollman M; Huck K; Stehle G; Heene DL
    Thromb Haemost; 1995 Aug; 74(2):673-9. PubMed ID: 8585005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)].
    Soria J; Soria C; de Rodriguez S; Horellou MH; Samama M; Bilski-Pasquier G
    Nouv Presse Med; 1977 Dec; 6(43):4045-8. PubMed ID: 600751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinopeptide A and the phosphate content of fibrinogen in venous thromboembolism and disseminated intravascular coagulation.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Ginkel CJ; van Aken WG; van Mourik JA
    Blood; 1986 May; 67(5):1460-7. PubMed ID: 3697510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of soluble fibrin oligomers in purified systems and in plasma.
    Alkjaersig N; Fletcher AP
    Biochem J; 1983 Jul; 213(1):75-83. PubMed ID: 6615433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
    Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
    Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
    Smith EB
    Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No discriminating power in FPA measurements during fibrinaemia in hip replaced patients generating DVT.
    Nilsen DW; Holm B; Kierulf P; Ruyter R; Godal HC
    Scand J Clin Lab Invest Suppl; 1985; 178():121-5. PubMed ID: 2418489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive ethanol gelation test associated with high plasma fibrinogen concentration - evidence for soluble fibrin. An experimental study in rabbits.
    Slaastad RA; Jakobsen E; Godal HC
    Scand J Haematol; 1975 Oct; 15(3):192-200. PubMed ID: 1198062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stimulatory effect of soluble fibrin on plasminogen activation by tissue plasminogen activator as studied by the Coa-set Fibrin Monomer test.
    Halvorsen S; Skjønsberg OH; Godal HC
    Thromb Res; 1991 Feb; 61(4):453-61. PubMed ID: 1905851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.